Mentions
Extended reach
Total likes
Video views
AI synopsis
Participants express keen interest through questions like 'Maybe we need to wait 10 more years?' and references to ongoing trials, reflecting curiosity and concern about long-term outcomes. The tone varies from skepticism to analytical, with phrases like 'unable to make sense of these results' showing a desire for deeper understanding, contributing to a moderate engagement level and recognizing the potential impact on clinical decisions.
The discussions show mixed reactions, with some users questioning the findings and others referencing related studies, indicating neither full agreement nor disagreement.
The discussions reflect high interest, as users are engaging with the topic, questioning results, and referencing related research, demonstrating genuine curiosity.
There is a moderate level of engagement with some comments questioning the implications and referencing other studies, but limited in-depth analysis.
The discussions may influence opinions among clinicians and patients, though no clear consensus suggests a significant shift in practice yet.
Was there really more enthusiasm in 1994 to debate than determine the truth? #pcsm #radonc @VickersBiostats @BehfarEhdaieMD Final study results: https://t.co/vzm6wljf6e https://t.co/DYtXwylO5V
https://t.co/Zjvbjit43F https://t.co/w9A8EcUbDr Please share with the urologist community as I’m unable to make sense of these results. #prostatecancer
Interesting that Wilt’s #PIVOT study (RP vs WW for screen detected ds) with >19y mFU, there was no difference in OS or CSS. Maybe we need to wait 10 more years? https://t.co/1TTNnwMSuN https://t.co/Gj4lz0vvFb
CHIEF PIVOT Trial Prostate cancer intervention vs observation https://t.co/MtKi5hhnCl
Follow-up of Prostatectomy versus Observation for Early Prostate Cancer https://t.co/SnD4wI5IbH
RT @NEJM: Original Article: Follow-up of Prostatectomy versus Observation for Early Prostate Cancer https://t.co/FiweawbSsu #VisualAbstract…
Prostate biopsies may cause more harm than good, including complications and cancer spread. Many prostate cancers are nonaggressive, so understanding safer, evidence-based monitoring options is essential for informed…
Managing an Elevated PSA and avoiding unnecessary prostate biopsies. Dr. Stephen Petteruti discusses when a measured approach is best, highlighting alternatives like advanced imaging and lifestyle changes to support…
This episode examines the risks behind traditional PSA tests and prostate biopsies, challenging conventional protocols. Dr. Stephen Petteruti explores alternative approaches to prostate health, emphasizing proactive…
The Intellectual Medicine Approach offers a proactive strategy to fight prostate cancer, emphasizing vitality preservation and alternative therapies. This method aims to help men address the disease head-on while…
Whats the truth about prostate cancer treatments. There are many options including surgery, radiation, and focal therapies, but current evidence does not conclusively show they save many lives. The risk of complications…
Prostate cancer awareness campaigns often rely on ineffective tests. PSA blood tests and digital rectal exams have high false positive rates and limited reliability, failing to significantly reduce mortality. This video…
Whats the truth about the PSA test? The PSA test is highly unreliable with a high false positive rate and no proven mortality benefit. Most prostate cancers are outlived, and screening may cause more harm than good.
Prostate health refers to the wellbeing of the prostate gland, a crucial organ in male reproductive and urinary health. Prostate cancer awareness programs aim to promote screenings and support, but recent studies…
Men's Health Month in June aims to raise awareness of preventable health issues, promote early detection, and encourage healthy lifestyles. It also includes prostate cancer awareness, which focuses on early screening…
https://t.co/Zjvbjit43F https://t.co/w9A8EcUbDr Please share with the urologist community as I’m unable to make sense of these results. #prostatecancer
Interesting that Wilt’s #PIVOT study (RP vs WW for screen detected ds) with >19y mFU, there was no difference in OS or CSS. Maybe we need to wait 10 more years? https://t.co/1TTNnwMSuN https://t.co/Gj4lz0vvFb
CHIEF PIVOT Trial Prostate cancer intervention vs observation https://t.co/MtKi5hhnCl
Was there really more enthusiasm in 1994 to debate than determine the truth? #pcsm #radonc @VickersBiostats @BehfarEhdaieMD Final study results: https://t.co/vzm6wljf6e https://t.co/DYtXwylO5V
Follow-up of Prostatectomy versus Observation for Early Prostate Cancer https://t.co/SnD4wI5IbH
RT @NEJM: Original Article: Follow-up of Prostatectomy versus Observation for Early Prostate Cancer https://t.co/FiweawbSsu #VisualAbstract…